JP2011524537A5 - - Google Patents

Download PDF

Info

Publication number
JP2011524537A5
JP2011524537A5 JP2011514757A JP2011514757A JP2011524537A5 JP 2011524537 A5 JP2011524537 A5 JP 2011524537A5 JP 2011514757 A JP2011514757 A JP 2011514757A JP 2011514757 A JP2011514757 A JP 2011514757A JP 2011524537 A5 JP2011524537 A5 JP 2011524537A5
Authority
JP
Japan
Prior art keywords
sample
cancer
globo
bound
mixing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011514757A
Other languages
English (en)
Japanese (ja)
Other versions
JP5216139B2 (ja
JP2011524537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/047532 external-priority patent/WO2010008736A2/en
Publication of JP2011524537A publication Critical patent/JP2011524537A/ja
Publication of JP2011524537A5 publication Critical patent/JP2011524537A5/ja
Application granted granted Critical
Publication of JP5216139B2 publication Critical patent/JP5216139B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011514757A 2008-06-16 2009-06-16 GloboHおよびその断片に対する抗体のレベルに基づく癌の診断方法 Active JP5216139B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6197408P 2008-06-16 2008-06-16
US61/061,974 2008-06-16
PCT/US2009/047532 WO2010008736A2 (en) 2008-06-16 2009-06-16 Cancer diagnosis based on levels of antibodies against globo h and its fragments

Publications (3)

Publication Number Publication Date
JP2011524537A JP2011524537A (ja) 2011-09-01
JP2011524537A5 true JP2011524537A5 (enExample) 2012-01-19
JP5216139B2 JP5216139B2 (ja) 2013-06-19

Family

ID=41431641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011514757A Active JP5216139B2 (ja) 2008-06-16 2009-06-16 GloboHおよびその断片に対する抗体のレベルに基づく癌の診断方法

Country Status (11)

Country Link
US (1) US8158367B2 (enExample)
EP (1) EP2307887B1 (enExample)
JP (1) JP5216139B2 (enExample)
KR (1) KR101324109B1 (enExample)
CN (1) CN102066940B (enExample)
AU (1) AU2009271411B2 (enExample)
CA (1) CA2728574C (enExample)
ES (1) ES2477549T3 (enExample)
MX (1) MX2010013931A (enExample)
NZ (1) NZ590064A (enExample)
WO (1) WO2010008736A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
JP5986745B2 (ja) 2008-07-15 2016-09-06 アカデミア シニカAcademia Sinica Ptfe様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US8957107B2 (en) 2009-12-15 2015-02-17 The Hospital For Sick Children Method of treating scars and β-catenin-mediated disorders using Nefopam compounds
WO2011130332A1 (en) 2010-04-12 2011-10-20 Academia Sinica Glycan arrays for high throughput screening of viruses
US10132817B2 (en) 2011-07-12 2018-11-20 Rowan University Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014018903A1 (en) * 2012-07-27 2014-01-30 Rowan University Autoantibody profiles in early detection and diagnosis of cancer
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカAcademia Sinica 改変されたグリコシル基を含む糖脂質を用いたヒトiNKT細胞の活性化
CN104698183A (zh) * 2013-12-04 2015-06-10 苏州中赢医疗科技有限公司 一种肝癌肿瘤标志物、其抗体及应用
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
TW201620939A (zh) 2014-01-16 2016-06-16 中央研究院 治療及檢測癌症之組合物及方法
MX2016012124A (es) 2014-03-19 2017-04-06 Mackay Medical Found The Presbyterian Church In Taiwan Mackay Memorial Hospital Anticuerpos contra glicopeptidos inmunogenicos, composicion que los comprende y usos de estos.
EP3129767B1 (en) 2014-03-27 2021-09-01 Academia Sinica Reactive labelling compounds and uses thereof
CA3104268A1 (en) 2014-04-10 2015-10-15 Obi Pharma Inc. Antibodies, pharmaceutical compositions and uses thereof
KR20170003720A (ko) 2014-05-27 2017-01-09 아카데미아 시니카 항-cd20 글리코항체 및 이의 용도
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
AU2015267045B2 (en) 2014-05-27 2021-02-25 Academia Sinica Anti-HER2 glycoantibodies and uses thereof
DK3149045T3 (da) 2014-05-27 2023-03-06 Academia Sinica Sammensætninger og fremgangsmåder vedrørende universelle glycoformer til forbedret antistofeffekt
JP7063538B2 (ja) 2014-05-28 2022-05-09 アカデミア シニカ 抗TNFα糖操作抗体群およびその使用
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
KR102630294B1 (ko) 2015-01-24 2024-01-26 아카데미아 시니카 암 마커 및 이를 사용하는 방법
US10342858B2 (en) 2015-01-24 2019-07-09 Academia Sinica Glycan conjugates and methods of use thereof
TWI717333B (zh) 2015-01-30 2021-02-01 中央研究院 增進抗體功效之通用糖型組合物及方法
JP6822957B2 (ja) * 2015-07-30 2021-01-27 京セラ株式会社 測定方法、および測定装置
JP2018532990A (ja) * 2015-09-04 2018-11-08 オービーアイ ファーマ,インコーポレイテッド グリカンアレイおよび使用の方法
AU2017231749A1 (en) 2016-03-08 2018-09-20 Academia Sinica Methods for modular synthesis of N-glycans and arrays thereof
EP3491026A4 (en) * 2016-07-29 2020-07-29 OBI Pharma, Inc. HUMAN ANTIBODIES, PHARMACEUTICAL COMPOSITIONS AND PROCESSES
AU2017316663B2 (en) 2016-08-22 2024-02-22 CHO Pharma Inc. Antibodies, binding fragments, and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0996455B1 (en) 1997-04-16 2009-12-16 Sloan-Kettering Institute For Cancer Research Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof
CN1235831A (zh) * 1999-03-02 1999-11-24 第一军医大学珠江医院 含红细胞糖苷脂的药物组合物及其应用
US20020006629A1 (en) * 2000-02-29 2002-01-17 Danishefsky Samuel J. Affinity matrix bearing tumor-associated carbohydrate-or glycopeptide-based antigens and uses thereof
WO2006068758A2 (en) 2004-11-19 2006-06-29 The Scripps Research Institute Detection, prevention and treatment of breast cancer
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
US20090162405A1 (en) * 2006-12-14 2009-06-25 Yong Qian Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
JP2011524375A (ja) * 2008-06-16 2011-09-01 アカデミア シニカ GloboHおよびSSEA3に特異的な免疫反応を誘起する組成物および癌治療におけるその使用

Similar Documents

Publication Publication Date Title
BR112013010213A2 (pt) anticorpos que unem ligantes solúveis de receptores de célula t
MY172290A (en) Immunochromatography devices, methods, and, kits
WO2010065568A3 (en) METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
JP2014508298A5 (enExample)
WO2016094761A3 (en) Test apparatus and methods for st2 cardiac biomarker
WO2013132347A3 (en) Improved elisa immunoassay for calprotectin
Nel et al. Individual profiling of circulating tumor cell composition and therapeutic outcome in patients with hepatocellular carcinoma
WO2011109372A8 (en) Ultra-sensitive detection of molecules using dual detection methods
MX2013012143A (es) Inmunoensayo.
JP2008530582A5 (enExample)
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
RU2015104737A (ru) Способ обнаружения мультиспецифического связывающего агента
MX349661B (es) Metodo para la deteccion de una molecula de union de un enlazador multiespecifico.
WO2011147563A8 (de) Verfahren zur elektrochemischen detektion von bindungsreaktionen
WO2009121024A3 (en) Methods for detecting antibodies
DK2791675T3 (da) Måling af autoantistoffer under lav ledeevne-betingelser
JP2017026631A5 (enExample)
WO2012159072A3 (en) Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins
WO2005103698A3 (en) Methods and antibodies for nitrofuran detection
JP2015508500A5 (enExample)
WO2008025964A3 (en) Antibodies to an epitope of agr2. assays and hybridomas
EA200702361A1 (ru) АНТИТЕЛА ПРОТИВ csPCNA ИЗОФОРМЫ И ИХ ПРИМЕНЕНИЕ
Li et al. Circulating tumor cell detection in epithelial ovarian cancer using dual-component antibodies targeting EpCAM and FRα
WO2009066787A1 (ja) 血液試料の品質評価方法
JP2012531612A5 (enExample)